SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-003309
Filing Date
2023-03-09
Accepted
2023-03-09 16:07:19
Documents
15
Period of Report
2023-03-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K olma-20230309x8k.htm   iXBRL 8-K 38633
2 EX-99.1 olma-20230309xex99d1.htm EX-99.1 155436
3 GRAPHIC olma-20230309xex99d1001.jpg GRAPHIC 6681
  Complete submission text file 0001558370-23-003309.txt   425182

Data Files

Seq Description Document Type Size
4 EX-101.SCH olma-20230309.xsd EX-101.SCH 3238
5 EX-101.LAB olma-20230309_lab.xml EX-101.LAB 632
6 EX-101.PRE olma-20230309_pre.xml EX-101.PRE 10398
9 EXTRACTED XBRL INSTANCE DOCUMENT olma-20230309x8k_htm.xml XML 4819
Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39712 | Film No.: 23719770
SIC: 2834 Pharmaceutical Preparations